Atossa Therapeutics Inc
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develop… Read more
Market Cap & Net Worth: Atossa Therapeutics Inc (YAG2)
Atossa Therapeutics Inc (F:YAG2) has a market capitalization of $894.99 Million (€871.91 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #18751 globally and #1992 in its home market, demonstrating a 1120.61% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Atossa Therapeutics Inc's stock price €6.75 by its total outstanding shares 129171424 (129.17 Million).
Atossa Therapeutics Inc Market Cap History: 2015 to 2026
Atossa Therapeutics Inc's market capitalization history from 2015 to 2026. Data shows change from $6.92 Billion to $894.99 Million (-24.33% CAGR).
Atossa Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Atossa Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of YAG2 by Market Capitalization
Companies near Atossa Therapeutics Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Atossa Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Atossa Therapeutics Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Atossa Therapeutics Inc's market cap moved from $6.92 Billion to $ 894.99 Million, with a yearly change of -24.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €894.99 Million | +1127.27% |
| 2025 | €72.93 Million | -42.71% |
| 2024 | €127.29 Million | +3.84% |
| 2023 | €122.58 Million | +92.00% |
| 2022 | €63.84 Million | -65.71% |
| 2021 | €186.16 Million | +100.06% |
| 2020 | €93.05 Million | -51.93% |
| 2019 | €193.58 Million | +83.42% |
| 2018 | €105.54 Million | -73.36% |
| 2017 | €396.18 Million | -79.04% |
| 2016 | €1.89 Billion | -72.69% |
| 2015 | €6.92 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Atossa Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $894.99 Million USD |
| MoneyControl | $894.99 Million USD |
| MarketWatch | $894.99 Million USD |
| marketcap.company | $894.99 Million USD |
| Reuters | $894.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.